FDA DEVICE FACTS
Sapphire Pro Powder-Free Royal Blue Nitrile Exam Gloves
American Nitrile Operations, LLC
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
A powder-free patient examination glove is a disposable device intended for medical purposes that is worn on the examiner's hand to prevent contamination between patient and examiner. The glove was tested for use with Chemotherapy Drugs and Fentanyl Citrate as per ASTM D6978-05 Standard Practice for Assessment for Medical Gloves to Permeation by Chemotherapy Drugs. The list of Fentanyl and Chemotherapy Drugs tested (with breakthrough times) are: Chemotherapy Drug and Concentration Breakthrough Time (minutes) Carmustine (BNCU) (3.3 mg/ml) 25.5 Cyclophosphamide (20.0 mg/ml) >240 Doxorubicin HCl (2.0 mg/ml) >240 Etoposide (20.0 mg/ml) >240 5-Fluorouracil (50.0 mg/ml) >240 Methotrexate (25.0 mg/ml) >240 Paclitaxel (6.0 mg/ml) >240 Thiotepa (10.0 mg/ml) 47.7 Vincristine Sulfate (1.0 mg/ml) >240 Fentanyl (100mcg/2ml) >240 CAUTION: Testing showed an average breakthrough time of 25.5 min for Carmustine and 47.7 min for Thiotepa.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。